Point-of-Care Cholesterol Monitoring Device Market Opportunity Analysis by 2028 : Abaxis, Inc., Abbott Laboratories, SD Biosensor, Inc., Jant Pharmacal Corporation
A new Future Market Insights' study on the global sales scenario for point of care cholesterol monitoring devices projects just-under 3% year over year revenue growth for the market estimated to cross US$ 400 million in 2019.
View full press release